Report Adverse Events: Patients can submit adverse event reports to the FDA through the MedWatch program
And the answers are no, no, and no, said Alice Yuk-Yan Cheng, MD, an associate professor of medicine at University of Toronto, during a presentation on the retatrutide trial results at an American Diabetes Association meeting on June 6
Our simple online process allows you to skip the waiting rooms and start your weight loss journey with just a few taps on your phone or computer
This has prompted drug makers to release dedicated weight-loss versions of these diabetes drugs as well
Given the rapid pace of new clinical data, it is likely that guidelines will continue to evolve
Post-treatment, the cells were washed with 1X phosphate-buffered saline and stained with 15 M DCFDA-H2 or 5 M MitoSOX for 15 min at 37 C